HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ubiquinol supplementation protects against renal ischemia and reperfusion injury in rats.

Abstract
Generation of toxic oxygen metabolites followed by oxidant- and inflammatory-mediated tissue injury plays a crucial role in the pathogenesis of ischemia and reperfusion (IR). Ubiquinol, the reduced form of coenzyme Q10, is recognized for its potent antioxidant and anti-inflammatory properties in biological membranes. The present study was established to examine the possible protective effect of ubiquinol against renal IR injury. Groups of male Wistar rats were assigned into sham, ubiquinol, IR (45-min bilateral renal ischemia followed by 24-h reperfusion), and ubiquinol+ IR (ubiquinol 300 mg/kg given orally for 7 consecutive days before IR induction). Renal morphology, function, oxidative stress, and inflammatory markers were evaluated at the end of reperfusion. IR caused renal dysfunction as shown by significant increases in blood urea nitrogen, plasma creatinine, and a decrease in creatinine clearance. Light and electron microscopic examinations exhibited severe tubular damages and abnormal mitochondrial structure. IR-induced renal injuries were associated with significant increases in malondialdehyde, nitric oxide, tumor necrosis factor-α, but decreases in antioxidant thiols and superoxide dismutase. Pretreatment with ubiquinol obviously attenuated all the changes caused by IR, whereas it had no considerable effect in the sham-operated rats. These findings indicate that supplementation of ubiquinol prior to IR incidence confers functional and morphological protection to the ischemic kidney by maintaining the redox balance and regulating the generation of inflammatory mediator. The outcomes suggest that ubiquinol may be a potential candidate to counteract organ dysfunction in conditions involving IR injury.
AuthorsW Peerapanyasut, K Thamprasert, O Wongmekiat
JournalFree radical research (Free Radic Res) Vol. 48 Issue 2 Pg. 180-9 (Feb 2014) ISSN: 1029-2470 [Electronic] England
PMID24151980 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antioxidants
  • Sulfhydryl Compounds
  • Tumor Necrosis Factor-alpha
  • Ubiquinone
  • Nitric Oxide
  • Malondialdehyde
  • Superoxide Dismutase
  • ubiquinol
Topics
  • Animals
  • Antioxidants (administration & dosage)
  • Blood Urea Nitrogen
  • Dietary Supplements
  • Drug Evaluation, Preclinical
  • Ischemia (drug therapy, metabolism)
  • Kidney (blood supply, drug effects, metabolism, pathology)
  • Male
  • Malondialdehyde (metabolism)
  • Nitric Oxide (metabolism)
  • Oxidative Stress (drug effects)
  • Rats
  • Rats, Wistar
  • Reperfusion Injury (metabolism, prevention & control)
  • Sulfhydryl Compounds (metabolism)
  • Superoxide Dismutase (metabolism)
  • Tumor Necrosis Factor-alpha (metabolism)
  • Ubiquinone (administration & dosage, analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: